Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (6690)	7/8/1998 9:30:00 PM
From: James Wright	Read Replies (4) \| Respond to of 29382

Amigo Thread Groupies <g> -- I'd like some second opinions. Last week I mentioned KNDL as a very attractive stock. However, I was doing well with my other holdings so I didn't buy KNDL at that time. Since then KNDL's been going up very nicely and I now have some cash after taking some profits (how 'bout 75% on LEAP in just one week!) The numbers look great -- 100% or higher earnings and revenues growth on a year to year quarterly basis for the last four quarters. The company provides contract research services to pharmaceutical companies, and thus is positioned very well to ride the continuing biotech and pharmaceutical boom. It also has been in the lead on consolidating that industry sector by successfully buying other contract laboratories that immediately add to the bottom line. Finally, the company has a 95% growth rate with a PE of 52, a RS rank of 95, an EPS rank of 99, and has just broken out of a five month base into new highs. (Oh -- I almost forgot to mention the small float of only 4.8 million, with only 26% institutional ownership.) My question is this: Buy now or do you think there will be a pull back? If a pull back, what would be a good target price? Thanks in advance for your, as always, very informed collective opinions. -- Jim P.S. Sandra -- did you take your profits and sell LEAP before the drop?